{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:23:20Z","timestamp":1792268600371,"version":"4.4.0"},"reference-count":323,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG047644"],"award-info":[{"award-number":["AG047644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS074969"],"award-info":[{"award-number":["NS074969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS090934"],"award-info":[{"award-number":["NS090934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["8,232,107"],"award-info":[{"award-number":["8,232,107"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007812","name":"University of Washington","doi-asserted-by":"publisher","award":["8,591,894"],"award-info":[{"award-number":["8,591,894"]}],"id":[{"id":"10.13039\/100007812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AACSF-18-564776"],"award-info":[{"award-number":["AACSF-18-564776"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016948","name":"Tau Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["US2013\/049333"],"award-info":[{"award-number":["US2013\/049333"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.cell.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T15:25:06Z","timestamp":1569511506000},"page":"312-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3054,"title":["Alzheimer Disease: An Update on Pathobiology and Treatment Strategies"],"prefix":"10.1016","volume":"179","author":[{"given":"Justin M.","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2019.09.001_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20180794","article-title":"Microbiome-microglia connections via the gut-brain axis","volume":"216","author":"Abdel-Haq","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial and its Follow-up Study","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","article-title":"A novel in\u00a0vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity","volume":"127","author":"Ahmed","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.54.3.588","article-title":"A randomized controlled trial of prednisone in Alzheimer\u2019s disease. Alzheimer\u2019s Disease Cooperative Study","volume":"54","author":"Aisen","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib5","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2019.09.001_bib6","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1093\/brain\/awv278","article-title":"Regional brain hypometabolism is unrelated to regional amyloid plaque burden","volume":"138","author":"Altmann","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer\u2019s disease facts and figures","volume":"15","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib9","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.2017.20373","article-title":"Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials","volume":"319","author":"Atri","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2019.09.001_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2019.09.001_bib12","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib13","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","article-title":"Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice","volume":"29","author":"Bales","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib15","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1074\/jbc.M111.288746","article-title":"Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of A\u03b2 uptake and degradation by astrocytes","volume":"287","author":"Basak","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.09.001_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU Next Generation Alzheimer\u2019s prevention trial: Adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/lam.12882","article-title":"Shifts in gut microbiota composition in an APP\/PSS1 transgenic mouse model of Alzheimer\u2019s disease during lifespan","volume":"66","author":"B\u00e4uerl","year":"2018","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.cell.2019.09.001_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1474-4422(07)70293-4","article-title":"Aspirin in Alzheimer\u2019s disease (AD2000): a randomised open-label trial","volume":"7","author":"Bentham","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib21","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib22","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","article-title":"Reducing human apolipoprotein E levels attenuates age-dependent A\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice","volume":"32","author":"Bien-Ly","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/nbdi.1995.0019","article-title":"Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing","volume":"2","author":"Biere","year":"1995","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","article-title":"Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding","volume":"11","author":"Biernat","year":"1993","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.cell.2019.09.001_bib25","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cell.2019.09.001_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trci.2019.01.001","article-title":"Plasma exchange for Alzheimer\u2019s disease Management by Albumin Replacement (AMBAR) trial: Study design and progress","volume":"5","author":"Boada","year":"2019","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"10.1016\/j.cell.2019.09.001_bib27","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","article-title":"Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice","volume":"171","author":"Bolmont","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10522-014-9538-8","article-title":"\u03b2-Amyloid peptides display protective activity against the human Alzheimer\u2019s disease-associated herpes simplex virus-1","volume":"16","author":"Bourgade","year":"2015","journal-title":"Biogerontology"},{"key":"10.1016\/j.cell.2019.09.001_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1474-4422(19)30139-5","article-title":"Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial","volume":"18","author":"Boxer","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib33","first-page":"1083","article-title":"N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI","volume":"263","author":"Brier","year":"2016","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1161591","article-title":"Amyloid-beta dynamics correlate with neurological status in the injured human brain","volume":"321","author":"Brody","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archneur.1988.00520250037015","article-title":"Reliability of the Washington University Clinical Dementia Rating","volume":"45","author":"Burke","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2018.10.011","article-title":"Effect of apolipoprotein E4 on\u00a0clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network","volume":"75","author":"Bussy","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cell.2019.09.001_bib37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib38","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","article-title":"Expression of human apolipoprotein E3 or E4 in the brains of Apoe-\/- mice: isoform-specific effects on neurodegeneration","volume":"19","author":"Buttini","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2353\/ajpath.2010.090973","article-title":"Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice","volume":"177","author":"Buttini","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-130872","article-title":"Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis","volume":"38","author":"Cano-Cuenca","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2013.06.024","article-title":"Herpes virus in Alzheimer\u2019s disease: relation to progression of the disease","volume":"35","author":"Carbone","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cell.2019.09.001_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2008-13209","article-title":"Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer\u2019s disease","volume":"13","author":"Carlsson","year":"2008","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib43","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib44","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1206446109","article-title":"Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood A\u03b2 clearance in a mouse model of \u03b2-amyloidosis","volume":"109","author":"Castellano","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nature22067","article-title":"Human umbilical cord plasma proteins revitalize hippocampal function in aged mice","volume":"544","author":"Castellano","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0197-0186(00)00128-5","article-title":"Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE\/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts","volume":"38","author":"Cedazo-M\u00ednguez","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.cell.2019.09.001_bib47","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/acs.molpharmaceut.7b00200","article-title":"Blood-Brain Barrier Penetrating Biologic TNF-\u03b1 Inhibitor for Alzheimer\u2019s Disease","volume":"14","author":"Chang","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cell.2019.09.001_bib48","doi-asserted-by":"crossref","first-page":"16m11312","DOI":"10.4088\/JCP.16m11312","article-title":"Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study","volume":"79","author":"Chen","year":"2018","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.cell.2019.09.001_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib50","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","article-title":"Treatment for Rheumatoid Arthritis and Risk of Alzheimer\u2019s Disease: A Nested Case-Control Analysis","volume":"30","author":"Chou","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cell.2019.09.001_bib51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in\u00a0vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-beta in\u00a0vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2019.09.001_bib54","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2019.09.001_bib56","unstructured":"Commissioner, O. of the (2019). Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA\u2019s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions."},{"key":"10.1016\/j.cell.2019.09.001_bib57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/auto.19048","article-title":"Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in\u00a0vitro and in\u00a0vivo","volume":"8","author":"Congdon","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.cell.2019.09.001_bib58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/hmg\/ddt402","article-title":"Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance","volume":"23","author":"Cook","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cell.2019.09.001_bib59","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib60","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2015.0607","article-title":"Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial","volume":"72","author":"Coric","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (PART): a common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib62","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","article-title":"Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation","volume":"288","author":"Crowe","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"issue":"13B","key":"10.1016\/j.cell.2019.09.001_bib63","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/j.1460-2075.1985.tb04132.x","article-title":"Image reconstruction of the Alzheimer paired helical filament","volume":"4","author":"Crowther","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2019.09.001_bib64","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models","volume":"22","author":"Cruz Hern\u00e1ndez","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","article-title":"Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice","volume":"114","author":"Dawson","year":"2001","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.cell.2019.09.001_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer\u2019s disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib68","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1371\/journal.pone.0001475","article-title":"No effect of one-year treatment with indomethacin on Alzheimer\u2019s disease progression: a randomized controlled trial","volume":"3","author":"de Jong","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2019.09.001_bib69","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cell.2014.10.016","article-title":"Lessons from a failed \u03b3-secretase Alzheimer trial","volume":"159","author":"De Strooper","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib70","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The Cellular Phase of Alzheimer\u2019s Disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib71","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib72","doi-asserted-by":"crossref","first-page":"eaag0481","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2018.00267","article-title":"Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer\u2019s Disease Brain","volume":"12","author":"DeVos","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib74","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib75","doi-asserted-by":"crossref","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.cell.2019.09.001_bib76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib78","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in\u00a0vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","article-title":"Classification and basic pathology of Alzheimer disease","volume":"118","author":"Duyckaerts","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","article-title":"Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk","volume":"12","author":"Efthymiou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib82","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer\u2019s Disease","volume":"378","author":"Egan","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib83","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized Trial of Verubecestat for Prodromal Alzheimer\u2019s Disease","volume":"380","author":"Egan","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s Disease-Associated \u03b2-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib85","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","article-title":"Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation","volume":"106","author":"Eisele","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib86","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib87","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in\u00a0vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2019.09.001_bib88","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib89","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1038\/s41467-019-10192-2","article-title":"The viral protein corona directs viral pathogenesis and amyloid aggregation","volume":"10","author":"Ezzat","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib90","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in\u00a0vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib92","doi-asserted-by":"crossref","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib93","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib94","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41467-018-08279-3","article-title":"Neuropathological correlates and genetic architecture of microglial activation in elderly human brain","volume":"10","author":"Felsky","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib95","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib97","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1074\/jbc.M805627200","article-title":"Conformational diversity of wild-type Tau fibrils specified by templated conformation change","volume":"284","author":"Frost","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.09.001_bib98","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jaci.2014.01.032","article-title":"APO\u03b54 is associated with enhanced in\u00a0vivo innate immune responses in human subjects","volume":"134","author":"Gale","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.cell.2019.09.001_bib99","doi-asserted-by":"crossref","first-page":"a024331","DOI":"10.1101\/cshperspect.a024331","article-title":"Antibody Therapeutics Targeting A\u03b2 and Tau","volume":"7","author":"Gallardo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib100","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1073\/pnas.1902672116","article-title":"Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment","volume":"116","author":"Gan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib101","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2019.09.001_bib102","first-page":"164","article-title":"Combination Therapy for Alzheimer\u2019s Disease: Perspectives of the EU\/US CTAD Task Force","volume":"6","author":"Gauthier","year":"2019","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib103","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib104","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib105","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"G\u00f3mez-Isla","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib106","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal \u03b2-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer\u00a0Disease Pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib108","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000320506.79811.da","article-title":"The logopenic\/phonological variant of primary progressive aphasia","volume":"71","author":"Gorno-Tempini","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib109","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"G\u00f6tz","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","article-title":"New insights into the role of TREM2 in Alzheimer\u2019s disease","volume":"13","author":"Gratuze","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib111","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2019.09.001_bib112","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0278-5846(88)90102-9","article-title":"Glutamate transmission and toxicity in Alzheimer\u2019s disease","volume":"12","author":"Greenamyre","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cell.2019.09.001_bib113","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","article-title":"Fibril structure of amyloid-\u03b2(1-42) by cryo-electron microscopy","volume":"358","author":"Gremer","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib114","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib115","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib116","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein E \u03b54 genotype in Alzheimer\u2019s disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cell.2019.09.001_bib117","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.20160833","article-title":"Unique pathological tau conformers from Alzheimer\u2019s brains transmit tau pathology in nontransgenic mice","volume":"213","author":"Guo","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib118","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib119","doi-asserted-by":"crossref","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","article-title":"Trafficking and proteolytic processing of APP","volume":"2","author":"Haass","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2019.09.001_bib121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/WAD.0000000000000291","article-title":"Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia","volume":"33","author":"Han","year":"2019","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.cell.2019.09.001_bib122","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib123","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","article-title":"Translating the biology of aging into novel therapeutics for Alzheimer disease","volume":"92","author":"Hara","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib124","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer\u2019s disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cell.2019.09.001_bib126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.05.056","article-title":"LC3-Associated Endocytosis Facilitates \u03b2-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer\u2019s Disease","author":"Heckmann","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib129","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMc1813435","article-title":"Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer\u2019s Disease","volume":"380","author":"Henley","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1326-5-31","article-title":"BACE1-\/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization","volume":"5","author":"Hitt","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib131","doi-asserted-by":"crossref","unstructured":"Holth, J.K., Fritschi, S.K., Wang, C., Pedersen, N.P., Cirrito, J.R., Mahan, T.E., Finn, M.B., Manis, M., Geerling, J.C., Fuller, P.M., et\u00a0al. (2019). The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science eaav2546.","DOI":"10.1126\/science.aav2546"},{"key":"10.1016\/j.cell.2019.09.001_bib132","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.92.21.9480","article-title":"Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line","volume":"92","author":"Holtzman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib133","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib134","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of Solanezumab for Mild Dementia Due to Alzheimer\u2019s Disease","volume":"378","author":"Honig","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib135","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib136","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and A\u03b2 metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib137","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and A\u03b2 Secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib138","doi-asserted-by":"crossref","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","article-title":"Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain","volume":"5","author":"Hudry","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib139","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2012.05.048","article-title":"Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice","volume":"1467","author":"Hunter","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.cell.2019.09.001_bib140","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2353\/ajpath.2010.100346","article-title":"Abeta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model","volume":"177","author":"Hurtado","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib141","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins","volume":"58","author":"Huynh","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cell.2019.09.001_bib142","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib143","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","article-title":"Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy","volume":"33","author":"Iba","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib144","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease","volume":"345","author":"in t\u2019 Veld","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib146","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib147","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib148","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer\u2019s disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib149","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains","volume":"33","author":"Jamieson","year":"1991","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.cell.2019.09.001_bib150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.1711670403","article-title":"Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type","volume":"167","author":"Jamieson","year":"1992","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib151","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib152","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib153","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib154","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1093\/brain\/awx148","article-title":"Slow wave sleep disruption increases cerebrospinal fluid amyloid-\u03b2 levels","volume":"140","author":"Ju","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib155","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib156","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib157","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cell.2019.09.001_bib158","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.24188","article-title":"A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease","volume":"76","author":"Karran","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib159","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2019.09.001_bib160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.1251141","article-title":"Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors","volume":"344","author":"Katsimpardi","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib161","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib162","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s13311-019-00746-z","article-title":"Plasma-Based Strategies for Therapeutic Modulation of Brain Aging","volume":"16","author":"Kheifets","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cell.2019.09.001_bib163","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/197192b0","article-title":"Paired helical filaments in electron microscopy of Alzheimer\u2019s disease","volume":"197","author":"Kidd","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib164","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1523\/JNEUROSCI.3773-11.2011","article-title":"Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-\u03b2 amyloidosis","volume":"31","author":"Kim","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib165","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1084\/jem.20121274","article-title":"Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis","volume":"209","author":"Kim","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib166","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"10.1016\/j.cell.2019.09.001_bib167","doi-asserted-by":"crossref","first-page":"14069","DOI":"10.1523\/JNEUROSCI.2281-14.2014","article-title":"Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice","volume":"34","author":"Knoferle","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib168","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2019.09.001_bib169","doi-asserted-by":"crossref","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib170","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2019.09.001_bib171","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13195-018-0340-8","article-title":"Safety, tolerability and immunogenicity of an active anti-A\u03b240 vaccine (ABvac40) in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase I trial","volume":"10","author":"Lacosta","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cell.2019.09.001_bib323","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","article-title":"BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions","volume":"25","author":"Laird","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib172","doi-asserted-by":"crossref","first-page":"e1002660","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.cell.2019.09.001_bib173","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib174","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib175","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib176","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","article-title":"Anti-ApoE antibody given after plaque onset decreases A\u03b2 accumulation and improves brain function in a mouse model of A\u03b2 amyloidosis","volume":"34","author":"Liao","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib177","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","article-title":"Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation","volume":"128","author":"Liao","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.cell.2019.09.001_bib178","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib179","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1074\/jbc.REV119.008031","article-title":"Elucidating Tau function and dysfunction in the era of cryo-EM","volume":"294","author":"Lippens","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2019.09.001_bib180","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in\u00a0vivo","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2019.09.001_bib181","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 Accelerates Early Seeding of Amyloid Pathology","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib182","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1083\/jcb.201806205","article-title":"A cellular complex of BACE1 and \u03b3-secretase sequentially generates A\u03b2 from its full-length precursor","volume":"218","author":"Liu","year":"2019","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.cell.2019.09.001_bib183","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2019.09.001_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-016-0181-2","article-title":"Safety and tolerability of BAN2401--a clinical study in Alzheimer\u2019s disease with a protofibril selective A\u03b2 antibody","volume":"8","author":"Logovinsky","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cell.2019.09.001_bib185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.trci.2019.02.005","article-title":"The Alzheimer\u2019s Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer\u2019s disease","volume":"5","author":"Lopez Lopez","year":"2019","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"10.1016\/j.cell.2019.09.001_bib186","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib187","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jalz.2019.03.016","article-title":"Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease","volume":"15","author":"Lowe","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib188","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.25117","article-title":"Effect of sleep on overnight cerebrospinal fluid amyloid \u03b2 kinetics","volume":"83","author":"Lucey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib189","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1750-3639.2007.00053.x","article-title":"Structural principles of tau and the paired helical filaments of Alzheimer\u2019s disease","volume":"17","author":"Mandelkow","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1567205014666170505095109","article-title":"The Involvement of Post-Translational Modifications in Alzheimer\u2019s Disease","volume":"15","author":"Marcelli","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cell.2019.09.001_bib191","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.24969","article-title":"Decreased plasma \u03b2-amyloid in the Alzheimer\u2019s disease APP A673T variant carriers","volume":"82","author":"Martiskainen","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib192","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib193","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib194","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","article-title":"A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology","volume":"10","author":"Matarin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib196","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib197","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.cell.2019.09.001_bib198","first-page":"CD003154","article-title":"Memantine for dementia","author":"McShane","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cell.2019.09.001_bib199","doi-asserted-by":"crossref","first-page":"e2070","DOI":"10.1212\/WNL.0000000000007232","article-title":"INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","volume":"92","author":"Meyer","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib200","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaneurol.2016.3185","article-title":"Preclinical Assessment of Young Blood Plasma for Alzheimer Disease","volume":"73","author":"Middeldorp","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib201","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib202","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib203","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1038\/srep30028","article-title":"Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease","volume":"6","author":"Minter","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib204","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE \u03b54 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib205","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer\u2019s disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"Suppl 1","key":"10.1016\/j.cell.2019.09.001_bib206","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/S1041610297004870","article-title":"Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.cell.2019.09.001_bib207","first-page":"153","article-title":"Editorial: Is Now the Time for Combination Therapies for Alzheimer Disease?","volume":"6","author":"Morris","year":"2019","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib208","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib209","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib210","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-019-0324-6","article-title":"Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease","volume":"14","author":"Najm","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance\u00a0plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib213","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.cell.2019.09.001_bib214","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in\u00a0vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib216","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer\u2019s disease","author":"Nicoll","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib217","doi-asserted-by":"crossref","first-page":"eaav9518","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib218","first-page":"63","article-title":"AADvac1, an Active Immunotherapy for Alzheimer\u2019s Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development","volume":"6","author":"Novak","year":"2019","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib219","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-017-01444-0","article-title":"Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology","volume":"8","author":"Nuriel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib220","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.celrep.2012.11.028","article-title":"\u03b3-secretase modulators and presenilin 1 mutants act differently on presenilin\/\u03b3-secretase function to cleave A\u03b242 and A\u03b243","volume":"3","author":"Okochi","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib221","article-title":"Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer\u2019s disease","volume":"41","author":"Olsson","year":"2018","journal-title":"Sleep (Basel)"},{"key":"10.1016\/j.cell.2019.09.001_bib222","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","article-title":"Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial","volume":"71","author":"Ooms","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib223","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib224","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13195-017-0318-y","article-title":"A phase III randomized trial of gantenerumab in prodromal Alzheimer\u2019s disease","volume":"9","author":"Ostrowitzki","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.cell.2019.09.001_bib225","doi-asserted-by":"crossref","first-page":"eaao5620","DOI":"10.1126\/scitranslmed.aao5620","article-title":"Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice","volume":"10","author":"Ou-Yang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib227","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related \u03b2-Amyloid Status","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib228","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/14737175.2018.1531706","article-title":"BACE inhibitors in clinical development for the treatment of Alzheimer\u2019s disease","volume":"18","author":"Panza","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.cell.2019.09.001_bib229","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","article-title":"Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE","volume":"22","author":"Parhizkar","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib230","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41467-019-10217-w","article-title":"A\u03b2-induced vulnerability propagates via the brain\u2019s default mode network","volume":"10","author":"Pascoal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib231","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-017-1804-9","article-title":"BACE1 inhibition more effectively suppresses initiation than progression of \u03b2-amyloid pathology","volume":"135","author":"Peters","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib232","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awz090","article-title":"A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer\u2019s disease dementia","volume":"142","author":"Pontecorvo","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.cell.2019.09.001_bib233","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease","volume":"3","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib234","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib236","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","article-title":"Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease","volume":"30","author":"Price","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cell.2019.09.001_bib237","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-018-0790-y","article-title":"Transmission of amyloid-\u03b2 protein pathology from cadaveric pituitary growth hormone","volume":"564","author":"Purro","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib238","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2018.02.016","article-title":"NLRP3-dependent synaptic plasticity deficit in an Alzheimer\u2019s disease amyloidosis model in\u00a0vivo","volume":"114","author":"Qi","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib239","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1326-6-88","article-title":"The Alzheimer\u2019s \u03b2-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb","volume":"6","author":"Rajapaksha","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale Analysis of Independent Alzheimer\u2019s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"issue":"Suppl 3","key":"10.1016\/j.cell.2019.09.001_bib241","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib242","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib243","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","article-title":"APOE effect on Alzheimer\u2019s disease biomarkers in older adults with significant memory concern","volume":"11","author":"Risacher","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib244","doi-asserted-by":"crossref","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","article-title":"Disruption of the sleep-wake cycle and diurnal fluctuation of \u03b2-amyloid in mice with Alzheimer\u2019s disease pathology","volume":"4","author":"Roh","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer\u2019s Disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.cell.2019.09.001_bib246","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib247","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1021\/acschemneuro.9b00143","article-title":"O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease","volume":"10","author":"Ryan","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib248","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41598-018-38218-7","article-title":"Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan","volume":"9","author":"Saji","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib249","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib250","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib251","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib252","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau Kinetics in Neurons and the Human Central Nervous System","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib253","doi-asserted-by":"crossref","first-page":"10172","DOI":"10.1073\/pnas.1811411115","article-title":"Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy","volume":"115","author":"Sayed","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib254","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib255","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2018.08.022","article-title":"Widespread distribution of tauopathy in preclinical Alzheimer\u2019s disease","volume":"72","author":"Schultz","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.cell.2019.09.001_bib256","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41582-019-0205-1","article-title":"Alzheimer disease and aducanumab: adjusting our approach","volume":"15","author":"Selkoe","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib257","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib258","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer\u2019s pathology and rescues neuronal loss in\u00a0vivo","volume":"35","author":"Seren\u00f3","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib259","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamaneurol.2018.3288","article-title":"Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial","volume":"76","author":"Sha","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib261","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib262","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib263","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2019.09.001_bib264","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","article-title":"Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment","volume":"11","author":"Sohn","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib266","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.20171529","article-title":"Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism","volume":"215","author":"Song","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib267","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2019.09.001_bib268","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","article-title":"Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Sosna","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib269","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib270","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib271","doi-asserted-by":"crossref","first-page":"32228","DOI":"10.1038\/srep32228","article-title":"Amyloidogenic amyloid-\u03b2-peptide variants induce microbial agglutination and exert antimicrobial activity","volume":"6","author":"Spitzer","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib272","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1586\/14737175.2015.995168","article-title":"Charting a path toward combination therapy for Alzheimer\u2019s disease","volume":"15","author":"Stephenson","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.cell.2019.09.001_bib273","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib274","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib275","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1073\/pnas.0606298103","article-title":"Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by up-regulating BACE1 gene expression","volume":"103","author":"Sun","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib276","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib277","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/01.WNL.0000140289.18472.15","article-title":"Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy","volume":"63","author":"Tang-Wai","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib278","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.trci.2018.02.002","volume":"4","author":"Tariot","year":"2018","journal-title":"Alzheimers Dement. (N.\u00a0Y.)"},{"key":"10.1016\/j.cell.2019.09.001_bib279","doi-asserted-by":"crossref","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","article-title":"Genetics of \u03b2-Amyloid Precursor Protein in Alzheimer\u2019s Disease","volume":"7","author":"Tcw","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib280","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cell.2019.09.001_bib281","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.cell.2019.09.001_bib282","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-9-20","article-title":"Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2","volume":"9","author":"Ulrich","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.cell.2019.09.001_bib283","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib284","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-019-02026-8","article-title":"A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer\u2019s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity","volume":"138","author":"van der Lee","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.cell.2019.09.001_bib285","doi-asserted-by":"crossref","first-page":"e0163236","DOI":"10.1371\/journal.pone.0163236","article-title":"No Overt Deficits in Aged Tau-Deficient C57Bl\/6.Mapttm1(EGFP)Kit GFP Knockin Mice","volume":"11","author":"van Hummel","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2019.09.001_bib286","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trci.2016.12.003","article-title":"Active A\u03b2 immunotherapy CAD106 in Alzheimer\u2019s disease: A phase 2b study","volume":"3","author":"Vandenberghe","year":"2016","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"10.1016\/j.cell.2019.09.001_bib287","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.5665\/sleep.6240","article-title":"Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid A\u03b242 Levels in Cognitively Normal Elderly","volume":"39","author":"Varga","year":"2016","journal-title":"Sleep (Basel)"},{"key":"10.1016\/j.cell.2019.09.001_bib288","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib289","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156720509787602852","article-title":"Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders","volume":"6","author":"Vellas","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cell.2019.09.001_bib290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib291","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1523\/JNEUROSCI.0607-11.2011","article-title":"Opposing synaptic regulation of amyloid-\u03b2 metabolism by NMDA receptors in\u00a0vivo","volume":"31","author":"Verges","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib292","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib293","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","article-title":"Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype","volume":"15","author":"Vermunt","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.cell.2019.09.001_bib294","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm.3569","article-title":"Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice","volume":"20","author":"Villeda","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib295","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2019.09.001_bib296","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer\u2019s disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2019.09.001_bib297","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib298","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2017.08.001","article-title":"Modulation of \u03b3-\u00a0and \u03b2-Secretases as Early Prevention Against Alzheimer\u2019s Disease","volume":"83","author":"Voytyuk","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cell.2019.09.001_bib299","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/jpet.117.240861","article-title":"Pharmacological and Toxicological Properties of the Potent Oral \u03b3-Secretase Modulator BPN-15606","volume":"362","author":"Wagner","year":"2017","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cell.2019.09.001_bib300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","article-title":"Neurodegenerative diseases: expanding the prion concept","volume":"38","author":"Walker","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib301","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib302","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","article-title":"Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between \u03b2-Amyloid and Tauopathy","volume":"73","author":"Wang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib303","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib304","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nn.2476","article-title":"Amyloid beta from axons and dendrites reduces local spine number and plasticity","volume":"13","author":"Wei","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib305","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib306","first-page":"236","article-title":"Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer\u2019s Disease and Other Tauopathies","volume":"4","author":"West","year":"2017","journal-title":"J.\u00a0Prev. Alzheimers Dis."},{"key":"10.1016\/j.cell.2019.09.001_bib307","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the beta-secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib308","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","article-title":"Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines","volume":"93","author":"Wischik","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2019.09.001_bib309","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/path.2449","article-title":"Herpes simplex virus type 1 DNA is located within Alzheimer\u2019s disease amyloid plaques","volume":"217","author":"Wozniak","year":"2009","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.cell.2019.09.001_bib310","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2019.02.011","article-title":"\u03b3-Secretase and its modulators: Twenty years and beyond","volume":"701","author":"Xia","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cell.2019.09.001_bib311","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib312","first-page":"613","article-title":"Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women","volume":"306","author":"Yaffe","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cell.2019.09.001_bib313","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20131685","article-title":"Neuronal activity regulates extracellular tau in\u00a0vivo","volume":"211","author":"Yamada","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib314","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in\u00a0vitro markedly decrease pathology and improve cognition in\u00a0vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.cell.2019.09.001_bib315","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/acn3.176","article-title":"Anti-tau antibody reduces insoluble tau and decreases brain atrophy","volume":"2","author":"Yanamandra","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.cell.2019.09.001_bib316","doi-asserted-by":"crossref","first-page":"eaal2029","DOI":"10.1126\/scitranslmed.aal2029","article-title":"Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy","volume":"9","author":"Yanamandra","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2019.09.001_bib317","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0813-8","article-title":"Structural basis of Notch recognition by human \u03b3-secretase","volume":"565","author":"Yang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2019.09.001_bib318","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn.4117","article-title":"Persistence of A\u03b2 seeds in APP null mouse brain","volume":"18","author":"Ye","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cell.2019.09.001_bib319","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cell.2019.09.001_bib320","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE \u03b52 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2019.09.001_bib321","doi-asserted-by":"crossref","first-page":"eaaw0930","DOI":"10.1126\/science.aaw0930","article-title":"Recognition of the amyloid precursor protein by human \u03b3-secretase","volume":"363","author":"Zhou","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2019.09.001_bib322","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867419310074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867419310074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T06:48:29Z","timestamp":1717138109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867419310074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":323,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0092867419310074"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer Disease: An Update on Pathobiology and Treatment Strategies","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}